LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT) Stock Price, Financials & Summary

Price chart

Jun 23Jun 26Jul 1Jul 7Jul 10Jul 20Jul 23Jul 28

Key dataJul 28, 2026

Open$4.38

From 52W high−10.32%

Volume366100.00

Market cap$89.28M

P/E (TTM)—

P/S (TTM)—

Div yield—

Key dataJul 28, 2026

Open

$4.38

From 52W high

−10.32%

Volume

366100.00

Market cap

$89.28M

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−12.0x

P/E (TTM)

—

RSI (14)

33.6

MomentumView details →

1D Return

−6.00%

YTD Return

+12.72%

SummaryUpdated Mar 1, 2026

Lixte Biotechnology Holdings, Inc. (NASDAQ:LIXT) is a clinical-stage drug discovery company founded in 2005 and based in Pasadena, California. The company went public in 2007 and specializes in developing novel therapeutic compounds targeting protein phosphatases, a class of enzymes involved in cellular regulation. Lixte focuses on creating treatments for serious diseases including various cancers, vascular diseases, metabolic disorders, and rare hereditary conditions through its proprietary biomarker technology platform.

Ask drillr about LIXTE BIOTECHNOLOGY HOLDINGS, INC. →

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

−12.0x

EV/Sales

—

P/S (TTM)

—

P/B (TTM)

11.2x

ProfitabilityView details →

Gross Margin

—

Net Margin

—

EBITDA Margin

—

ROE (TTM)

−91.55%

ROA (TTM)

−66.95%

Asset Turnover

0.00x

GrowthView details →

Revenue YoY

—

EPS YoY

+22.07%

FCF YoY

—

Revenue CAGR 3Y

—

EPS CAGR 3Y

+20.75%

EBITDA YoY

—

MomentumView details →

1D Return

−6.00%

YTD Return

+12.72%

1Y Return

+15.67%

RSI (14)

33.6

vs 50D SMA

−29.33%

vs 200D SMA

+2.22%

Capital & dividendView details →

Debt/Equity

0.13x

Current Ratio

2.78x

Quick Ratio

2.78x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

−$0.18

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

0.00

Net Income (TTM)

−7.27M

Op. CF (TTM)

−4.33M

Latest newsMore news →

LIXTE Biotechnology Holdings completed its corporate name change to NOMAD Power Solutions, Inc.76d ago

LIXTE completed a merger with Nomad Transportable Power Systems.80d ago

Similar companies

ImmuCell CorporationICCC Rallybio CorporationRLYB Adicet Bio, Inc.ACET Fractyl Health, Inc. Common StockGUTS Neonc Technologies Holdings, Inc.NTHI Telomir Pharmaceuticals, Inc. Common StockTELO Find similar companies →

Latest newsMore news →

LIXTE Biotechnology Holdings completed its corporate name change to NOMAD Power Solutions, Inc.76d ago LIXTE completed a merger with Nomad Transportable Power Systems.80d ago LIXTE Biotechnology agreed to acquire NOMAD Transportable Power Systems, the market leader in mobile, utility-grade battery energy storage systems.100d ago